Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 2

1(14.3%)

Phase 1

1(14.3%)

7Total

N/A(5)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07093099Not ApplicableCompleted

Effect of Counseling and Education on Mechanical Bowel Preparation

Role: collaborator

NCT05389813Phase 2Unknown

Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia

Role: lead

NCT05271448Not ApplicableUnknown

Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography

Role: lead

NCT04125992Not ApplicableCompleted

Distal vs. Forearm Radial Artery Access

Role: lead

NCT04923295Not ApplicableCompleted

The Effect of Dapagliflozin on Ultrafiltration Among Peritoneal Dialysis Patients

Role: lead

NCT05409716Not ApplicableCompleted

Compressive Elastic Dressing Versus TR Band

Role: lead

NCT03288571Phase 1Unknown

Use of Wharton Jelly in Diabetic Nephropathy

Role: collaborator

All 7 trials loaded